Home
About
FAQ
History (1)
Is Myocardial Fibrosis a New Frontier for Discovery in Cardiotoxicity Related to the Administration of Anthracyclines?
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Rocha Lima, Caio Max
One or more keywords matched the following items that are connected to
Rocha Lima, Caio Max
Item Type
Name
Concept
Survival Analysis
Academic Article
Treatment of relapsed small-cell lung cancer--a focus on the evolving role of topotecan.
Academic Article
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma.
Academic Article
Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual.
Academic Article
Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B.
Academic Article
Role of combined-modality therapy in the management of locally advanced rectal cancer.
Academic Article
A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.
Academic Article
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.
Academic Article
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere.
Academic Article
Metastatic colorectal cancer: systemic treatment in the new millennium.
Academic Article
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.
Academic Article
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.
Search Criteria
Survival Analysis